STOCK TITAN

Unrivaled Brands Reports Second Quarter 2022 Financial Results

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Unrivaled Brands, Inc. (UNRV) reported a significant financial update for Q2 2022, with total revenue surging 511% to $17.56 million, driven by retail sales of $10.95 million and cultivation/distribution revenue of $6.61 million. Gross profit increased by 204% to $8.27 million compared to Q2 2021. However, selling, general, and administrative expenses escalated by 306% to $19.07 million, leading to an operating loss of $67.07 million, up 3,298% year-over-year, largely due to impairment charges of $55.73 million. The merger and acquisitions contributed to operational costs and workforce expansion.

Positive
  • Total revenue increased by 511% to $17.56 million year-over-year.
  • Gross profit rose by 204% to $8.27 million compared to Q2 2021.
Negative
  • Operating loss of $67.07 million, up 3,298% from the previous year.
  • SG&A expenses increased by 306% to $19.07 million, significantly impacting profitability.
  • Impairment charges of $55.73 million related to acquisitions.

SANTA ANA, Calif., Aug. 19, 2022 (GLOBE NEWSWIRE) -- Unrivaled Brands, Inc. (OTCQX: UNRV) ("Unrivaled" or the "Company"), a multi-state vertically integrated company focused on the cannabis sector with operations in California and Oregon, yesterday reported its second quarter 2022 financial results for the quarter ended June 30, 2022.

Financial Update

  • During the three months ended June 30, 2022, the Company generated total revenue of $17.56 million composed of retail revenue of $10.95 million and cultivation/distribution revenue of $6.61 million. This compared to total revenue of $2.87 million for the quarter ended June 30, 2021, which included retail revenue of $2.32 million and cultivation/distribution revenue of $0.55 million. This was an increase of 511.0% in total revenue.
  • The Company’s gross profit for the three months ended June 30, 2022 was $8.27 million, compared to a gross profit of $2.72 million for the three months ended June 30, 2021, an increase of $5.55 million or 204.0%.
  • The merger with UMBRLA and the acquisitions of People's First Choice and SilverStreak Solutions in 2021 led to more operations with additional facilities, employees, and costs to support them. Selling, general and administrative expenses for the three months ended June 30, 2022 were $19.07 million, compared to $4.70 million for the three months ended June 30, 2021, an increase of $14.37 million or 305.9%. For the three months ended June 30, 2022, amortization and depreciation expenses increased by $2.56 million over the three months ended June 30, 2021, facilities related expenses, such as rent, utilities, repairs and maintenance, security, and insurance, increased by $2.89 million over second quarter of 2021. Taxes, licensing and permitting increased by $1.17 million. Advertising increased by $0.73 million. Employee related expenses increased by $3.93 million or 382%.
  • The Company realized an operating loss of $67.07 million for the three months ended June 30, 2022 compared to an operating loss of $1.97 million for the three months ended June 30, 2021, an increase of $65.09 million or 3,298.5%. This increase was attributed primarily to a $55.73 million charge for impairment of intangible assets and goodwill related to the UMBRLA and People's acquisitions.

About Unrivaled Brands

Unrivaled Brands is a multi-state vertically integrated company focused on the cannabis sector with operations in California and Oregon. In California, Unrivaled Brands operates dispensaries, direct to consumer delivery, a state-wide distribution network, company-owned brands, and two cultivation facilities. In Oregon, we operate a state-wide distribution network, company-owned brands and outdoor and greenhouse cultivation. Unrivaled Brands is home to Korova, the market leader in high potency products across multiple product categories, currently available in California, Oregon, Arizona, and Oklahoma, as well as Sticks and Cabana.

For more info, please visit: https://unrivaledbrands.com.

Cautionary Language Concerning Forward-Looking Statements

Certain statements contained in this communication regarding matters that are not historical facts, are forward-looking statements within the meaning of Section 21E of the Securities and Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, known as the PSLRA. These include statements regarding management's intentions, plans, beliefs, expectations, or forecasts for the future, and, therefore, you are cautioned not to place undue reliance on them. No forward-looking statement can be guaranteed, and actual results may differ materially from those projected. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise, except to the extent required by law. We use words such as "anticipates," "believes," "plans," "expects," "projects," "future," "intends," "may," "will," "should," "could," "estimates," "predicts," "potential," "continue," "guidance," and similar expressions to identify these forward-looking statements that are intended to be covered by the safe-harbor provisions of the PSLRA. Such forward-looking statements are based on our expectations and involve risks and uncertainties; consequently, actual results may differ materially from those expressed or implied in the statements due to a number of factors.

New factors emerge from time-to-time and it is not possible for us to predict all such factors, nor can we assess the impact of each such factor on the business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. These risks, as well as other risks associated with the combination, will be more fully discussed in our reports with the SEC. Additional risks and uncertainties are identified and discussed in the "Risk Factors" section of the Company's Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other documents filed from time to time with the SEC. Forward-looking statements included in this release are based on information available to Company as of the date of this release. The Company undertakes no obligation to update such forward-looking statements to reflect events or circumstances after the date of this release.

Contact
Jason Assad
LR Advisors LLC.
jassad@unrivaledbrands.com
678-570-6791

    
UNRIVALED BRANDS, INC. and Subsidiaries Consolidated Balance Sheets June 30,
2022
December 31,
2021
 
 (Unaudited)  
ASSETS   
Current assets:   
Cash$7,263 $6,891  
Accounts receivable, net 855  4,677  
Inventory, net 6,038  7,179  
Prepaid expenses and other assets 3,084  1,272  
Notes receivable 375  750  
Current assets held for sale 582  4,495  
Total current assets 18,197  25,264  
    
Property, equipment and leasehold improvements, net 21,416  23,728  
Intangible assets, net 102,772  129,637  
Goodwill 14,506  48,132  
Other assets 19,359  26,915  
Investments 1,214  163  
Long-term assets held for sale 2,791  17,984  
TOTAL ASSETS$180,255 $271,824  
    
LIABILITIES AND STOCKHOLDERS’ EQUITY   
LIABILITIES:   
Current liabilities:   
Accounts payable and accrued expenses$37,148 $31,904  
Short-term debt 26,532  45,749  
Income taxes payable 9,913  7,969  
Current liabilities held for sale 1,851  2,087  
Total current liabilities 75,444  87,708  
    
Long-term liabilities:   
Long-term debt, net of discounts 7,638  10,006  
Deferred tax liabilities 3,986  6,123  
Long-term lease liabilities 14,471  21,316  
Long-term liabilities held for sale 1,465  184  
Total long-term liabilities 27,560  37,629  
Total liabilities 103,004  125,337  
    
STOCKHOLDERS’ EQUITY:   
Common stock, par value $0.001:   
990,000,000 shares authorized as of June 30, 2022 and December 31, 2021; 532,514,803 shares issued and 530,206,383 shares outstanding as of June 30, 2022; 498,546,295 shares issued and 496,237,883 shares outstanding as of December 31, 2021. 554  521  
Additional paid-in capital 401,214  392,930  
Treasury stock (808) (808) 
Accumulated deficit (323,710) (250,015) 
Total Unrivaled Brands, Inc. Stockholders’ Equity 77,251  142,628  
Non-controlling interest   3,859  
Total stockholders’ equity 77,251  146,487  
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY$180,255 $271,824  
    


     
UNRIVALED BRANDS, INC. and Subsidiaries Consolidated Statement of Operations Three Months Ended
June 30,
Six Months Ended
June 30,
  2022  2021  2022  2021 
     
Total revenues$17,556 $2,872 $38,280 $4,928 
Cost of goods sold 9,286  147  23,578  2,013 
Gross profit 8,270  2,725  14,702  2,915 
     
Selling, general and administrative expenses 19,070  4,698  37,837  17,347 
Impairment of assets 55,726    55,726   
Loss on sale of assets 542    343   
Loss from operations (67,068) (1,973) (79,204) (14,432)
     
Other income (expense):    
Gain (loss) on extinguishment of debt     542  (6,161)
Interest expense, net (443) (39) (2,210) (112)
Unrealized gain on investments 963    963   
Other income 443  17  1,477  362 
Gain (loss) on investments   (874)   5,337 
Total other income (expense) 963  (896) 773  (574)
     
Loss from continuing operations, before provision for income taxes (66,105) (2,869) (78,432) (15,006)
Provision for income tax benefit for continuing operations 449    2,136   
Net loss from continuing operations (65,655) (2,869) (76,295) (15,006)
     
Income (loss) from discontinued operations, before provision for income taxes 1,843  (2,101) 3,979  (1,663)
Provision for income tax benefit for discontinued operations 95       
Net income (loss) from discontinued operations 1,938  (2,101) 3,979  (1,663)
     
NET LOSS (63,718) (4,970) (72,317) (16,669)
     
Less: Loss attributable to non-controlling interest from continuing operations   (868)   (486)
Less: Income attributable to non-controlling interest from discontinued operations     275   
NET LOSS ATTRIBUTABLE TO UNRIVALED BRANDS, INC.$ (63,718)$ (4,102)$ (72,592)$ (16,183)
     
Loss from continuing operations per common share attributable to Unrivaled Brands, Inc. common stockholders – basic and diluted$(0.11)$(0.01)$(0.13)$(0.06)
Net Loss per common share attributable to Unrivaled Brands, Inc. common stockholders – basic and diluted$(0.11)$(0.02)$(0.13)$(0.07)
     
Weighted-average number of common shares outstanding – basic and diluted 575,973,609  258,897,777  572,176,041  248,066,926 
     

FAQ

What were Unrivaled Brands' total revenues for Q2 2022?

Unrivaled Brands reported total revenues of $17.56 million for Q2 2022.

How much did gross profit change in Q2 2022 compared to the previous year?

Gross profit increased by 204% to $8.27 million in Q2 2022 from $2.72 million in Q2 2021.

What was the operating loss recorded by Unrivaled Brands in Q2 2022?

The operating loss for Q2 2022 was $67.07 million, an increase of 3,298% year-over-year.

What factors led to the increase in expenses for Unrivaled Brands in Q2 2022?

Increased selling, general, and administrative expenses, including significant rises in employee-related costs and facility-related expenses, contributed to the increase.

Blum Holdings, Inc.

OTC:UNRV

UNRV Rankings

UNRV Latest News

UNRV Stock Data

58.12k
4.50M
41.85%
0.01%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Santa Ana